Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Etoposide, topoisomerase II and cancer
EL Baldwin, N Osheroff - Current Medicinal Chemistry-Anti …, 2005 - ingentaconnect.com
Etoposide is an important chemotherapeutic agent that is used to treat a wide spectrum of
human cancers. It has been in clinical use for more than two decades and remains one of …
human cancers. It has been in clinical use for more than two decades and remains one of …
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
DA Burden, N Osheroff - Biochimica et Biophysica Acta (BBA)-Gene …, 1998 - Elsevier
Topoisomerase II is a ubiquitous enzyme that is essential for the survival of all eukaryotic
organisms and plays critical roles in virtually every aspect of DNA metabolism. The enzyme …
organisms and plays critical roles in virtually every aspect of DNA metabolism. The enzyme …
Doxorubicin-induced cardiotoxicity: causative factors and possible interventions
IC Jones, CR Dass - Journal of Pharmacy and Pharmacology, 2022 - academic.oup.com
Abstract Objectives Doxorubicin (Dox) belongs to the anthracycline drug classification and is
a widely administered chemotherapeutic. However, Dox use in therapy is limited by its …
a widely administered chemotherapeutic. However, Dox use in therapy is limited by its …
Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism (∗)
SJ Froelich-Ammon, N Osheroff - Journal of Biological chemistry, 1995 - ASBMB
Although the one-dimensional sequence of DNA determines the genetic constitution of an
organism, topological relationships within the double helix modulate virtually every …
organism, topological relationships within the double helix modulate virtually every …
Secondary leukemias induced by topoisomerase-targeted drugs
CA Felix - Biochimica et Biophysica Acta (BBA)-Gene Structure …, 1998 - Elsevier
The major established cause of acute myeloid leukemia (AML) in the young is cancer
chemotherapy. There are two forms of treatment-related AML (t-AML). Each form has a de …
chemotherapy. There are two forms of treatment-related AML (t-AML). Each form has a de …
Structure and function of type II DNA topoisomerases.
PM Watt, ID Hickson - Biochemical Journal, 1994 - ncbi.nlm.nih.gov
INTRODUCTION The faithful replication and segregation of chromosomes as part of the cell
division cycle requires that topological changes be imposed upon cellular DNA …
division cycle requires that topological changes be imposed upon cellular DNA …
[КНИГА][B] Cancer chemotherapy and biotherapy: principles and practice
K Tew, OM Colvin, BA Chabner - 1996 - doctorlib.info
The alkylating agents are antitumor drugs that act through the covalent binding of alkyl
groups to cellular molecules. This binding is mediated by reactive intermediates formed from …
groups to cellular molecules. This binding is mediated by reactive intermediates formed from …
Therapy-related myelodysplasia and acute myeloid leukemia
S Bhatia - Seminars in oncology, 2013 - Elsevier
Therapy-related leukemia (myelodysplasia and acute myeloid leukemia—t-MDS/AML) is a
well-known complication of conventional chemoradiotherapy used to treat a variety of …
well-known complication of conventional chemoradiotherapy used to treat a variety of …
Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice
JM Fortune, N Osheroff - 2000 - Elsevier
Topoisomerase 11 is an essential enzyme that plays a role in virtually every cellular DNA
process. This enzyme interconverts different topological forms of DNA by passing one …
process. This enzyme interconverts different topological forms of DNA by passing one …
Merbarone inhibits the catalytic activity of human topoisomerase IIα by blocking DNA cleavage
JM Fortune, N Osheroff - Journal of Biological Chemistry, 1998 - ASBMB
Merbarone is a catalytic inhibitor of topoisomerase II that is in clinical trials as an anticancer
agent. Despite the potential therapeutic value of this drug, the mechanism by which it blocks …
agent. Despite the potential therapeutic value of this drug, the mechanism by which it blocks …